NRXS
LIVE

Serial Number

50129244

Owner

NEURAXIS, INC.

Attorney

Brian J. McGinnis

Filing Date

Sep 25, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NRXS Trademark

Serial Number: 50129244

NRXS is a trademark filed by NEURAXIS, INC. on September 25, 2026. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

NEURAXIS, INC. (20 trademarks)

829 S. ADAMS STREET
VERSAILLES, IN 47042

Entity Type: 03

Trademark Details

Filing Date

September 25, 2026

Registration Date

Not Registered

Goods & Services

medical devices, namely, devices for measuring pelvic floor dysfunction and rectal hypersensitivity for use in the diagnosis and treatment of chronic constipation; medical diagnostic apparatus for testing pelvic floor dysfunction and rectal hypersensitivity in the field of chronic constipation; medical devices and apparatus for medical screening testing of individuals with chronic constipation; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the field of chronic constipation; disposable medical devices for diagnosing and treating constipation; Medical apparatus, namely, electrical nerve stimulators; Medical device, namely, a non-implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral nerves; Medical apparatus consisting of percutaneously implantable arrays for transmitting current into auricular and peri-auricular tissue; Medical device for peripheral nerve and nerve field stimulation; Medical device consisting of a non-implantable modulating frequency generator and percutaneously implantable needle arrays for transmitting current into auricular and peri-auricular tissue for use in pain management and FGID (functional gastrointestinal disorders), namely, patient stimulator for auricular and peri-auricular peripheral nerve field neuromodulation therapy; Medical apparatus, for peripheral nerve field stimulation in cranial and peripheral nerves and occipital nerve branches, for pain control, FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea, functional nausea, abdominal migraine, Crohn's Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes in FGID co-morbidities, sleep disturbances, psychological disorders, including mood and anxiety, satiety and changes in autonomic nervous system and other types of sympathetically mediated pain

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 25, 2026 MAFR
NEW APPLICATION ENTERED
Sep 25, 2026 NWAP